Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND MEZZANINE EQUITY

v3.22.2.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) AND MEZZANINE EQUITY - 1 months ended Dec. 31, 2021 - USD ($)
Common Stock
Class A Common
Common Stock
Class V Common
Additional Paid in Capital
[1]
Accumulated Deficit
Redeemable Non-controlling Interests
Total
STOCKHOLDERS' EQUITY at Dec. 03, 2021 $ 4,158 $ 19,655 $ 312,945,752 $ (29,336,924)   $ 283,632,641
STOCKHOLDERS' EQUITY (in shares) at Dec. 03, 2021 41,578,890 196,553,523        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Loss       (10,081,200)   (10,081,200)
STOCKHOLDERS' EQUITY at Dec. 31, 2021 $ 4,158 $ 19,655 $ 312,945,752 $ (39,418,124)   $ 273,551,441
STOCKHOLDERS' EQUITY (in shares) at Dec. 31, 2021 41,578,890 196,553,523        
Balance at the beginning at Dec. 03, 2021         $ 1,833,838,872  
Increase (Decrease) in Temporary Equity [Roll Forward]            
Stock Compensation         4,635,142  
Net Loss         (47,856,729)  
Balance at the end at Dec. 31, 2021         $ 1,790,617,285  
[1] Included in the opening balance are transactions completed in connection with the Business Combinations, including the PIPE investment of $195.3 million (net of issuance costs), the equity consideration to P3 shareholders of $80.3 million, and the trust proceeds (net of redemptions) of $37.4 million.